Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 349

1.

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J.

Thorax. 2002 Mar;57(3):212-6.

2.

Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.

Steinkamp G, Schmitt-Grohe S, Döring G, Staab D, Pfründer D, Beck G, Schubert R, Zielen S.

Respir Med. 2008 Nov;102(11):1643-53. doi: 10.1016/j.rmed.2008.03.009. Epub 2008 Aug 12.

3.

Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.

Pirzada OM, McGaw J, Taylor CJ, Everard ML.

J Cyst Fibros. 2003 Jun;2(2):69-71.

4.
5.

Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.

Kabra SK, Pawaiya R, Lodha R, Kapil A, Kabra M, Vani AS, Agarwal G, Shastri SS.

J Cyst Fibros. 2010 Jan;9(1):17-23. doi: 10.1016/j.jcf.2009.09.001. Epub 2009 Oct 8.

7.

Long term azithromycin therapy in patients with cystic fibrosis.

Emiralioğlu N, Öztürk Z, Yalçın E, Doğru D, Özçelik U, Kiper N.

Turk J Pediatr. 2016;58(1):34-40.

8.

Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin.

Rotschild M, Elias N, Berkowitz D, Pollak S, Shinawi M, Beck R, Bentur L.

Clin Exp Med. 2005 Jul;5(2):80-5.

PMID:
16096858
9.

Macrolides in cystic fibrosis: is there a role?

Wolter JM, Seeney SL, McCormack JG.

Am J Respir Med. 2002;1(4):235-41. Review.

PMID:
14720043
10.

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.

Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW; Pulmozyme Early Intervention Trial Study Group.

J Pediatr. 2001 Dec;139(6):813-20.

PMID:
11743506
11.

Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.

Nguyen D, Emond MJ, Mayer-Hamblett N, Saiman L, Marshall BC, Burns JL.

Pediatr Pulmonol. 2007 Jun;42(6):533-41.

PMID:
17469154
12.

Azithromycin increases chloride efflux from cystic fibrosis airway epithelial cells.

Oliynyk I, Varelogianni G, Schalling M, Asplund MS, Roomans GM, Johannesson M.

Exp Lung Res. 2009 Apr;35(3):210-21. doi: 10.1080/01902140802534967.

PMID:
19337904
13.

Buccal adherence of Pseudomonas aeruginosa in patients with cystic fibrosis under long-term therapy with azithromycin.

Baumann U, Fischer JJ, Gudowius P, Lingner M, Herrmann S, Tümmler B, von der Hardt H.

Infection. 2001 Jan-Feb;29(1):7-11.

PMID:
11261763
14.

Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.

Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.

Pediatr Infect Dis J. 2007 Jan;26(1):8-12.

PMID:
17195698
15.

Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.

Milstone A, Patsimas J, Farzan D, Castaldo R, Singh H, Feurer I, Harnett J, Luke DR; PROPeR Use Study Group.

Clin Ther. 2005 Jun;27(6):926-39.

PMID:
16117993
16.

Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.

Hansen CR, Pressler T, Hoiby N, Johansen HK.

J Cyst Fibros. 2009 Jan;8(1):58-62. doi: 10.1016/j.jcf.2008.09.001. Epub 2008 Oct 11.

17.

Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.

Conway SP, Pond MN, Watson A, Etherington C, Robey HL, Goldman MH.

Thorax. 1997 Nov;52(11):987-93.

18.

[Azithromycin therapy in cystic fibrosis].

Máiz Carro L, Cantón Moreno R.

Med Clin (Barc). 2004 Mar 6;122(8):311-6. Review. Spanish.

PMID:
15030744
19.

Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.

Esmond G, Butler M, McCormack AM.

J Clin Nurs. 2006 Jan;15(1):52-60.

PMID:
16390524
20.

Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.

Phaff SJ, Tiddens HA, Verbrugh HA, Ott A.

J Antimicrob Chemother. 2006 Apr;57(4):741-6. Epub 2006 Feb 9.

PMID:
16469851

Supplemental Content

Support Center